These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 20664932
21. Esophageal cancer exhibits resistance to a novel IGF-1R inhibitor NVP-AEW541 with maintained RAS-MAPK activity. Bao XH, Takaoka M, Hao HF, Wang ZG, Fukazawa T, Yamatsuji T, Sakurama K, Sun DS, Nagasaka T, Fujiwara T, Naomoto Y. Anticancer Res; 2012 Jul; 32(7):2827-34. PubMed ID: 22753744 [Abstract] [Full Text] [Related]
27. Insulin-like growth factor-type 1 receptor inhibitor NVP-AEW541 enhances radiosensitivity of PTEN wild-type but not PTEN-deficient human prostate cancer cells. Isebaert SF, Swinnen JV, McBride WH, Haustermans KM. Int J Radiat Oncol Biol Phys; 2011 Sep 01; 81(1):239-47. PubMed ID: 21816290 [Abstract] [Full Text] [Related]
28. Inhibition of IGF-1R-dependent PI3K activation sensitizes colon cancer cells specifically to DR5-mediated apoptosis but not to rhTRAIL. Pennarun B, Kleibeuker JH, Oenema T, Stegehuis JH, de Vries EG, de Jong S. Anal Cell Pathol (Amst); 2010 Sep 01; 33(5):229-44. PubMed ID: 20978316 [Abstract] [Full Text] [Related]
37. Inhibition of cell growth and up-regulation of MAD2 in human oesophageal squamous cell carcinoma after treatment with the Src/Abl inhibitor dasatinib. Wang L, Guo B, Wang R, Jiang Y, Qin S, Liang S, Zhao Y, Guo W, Li K, Fan X. Clin Sci (Lond); 2012 Jan 01; 122(1):13-24. PubMed ID: 21751967 [Abstract] [Full Text] [Related]
38. Enhanced efficacy of IGF1R inhibition in pediatric glioblastoma by combinatorial targeting of PDGFRα/β. Bielen A, Perryman L, Box GM, Valenti M, de Haven Brandon A, Martins V, Jury A, Popov S, Gowan S, Jeay S, Raynaud FI, Hofmann F, Hargrave D, Eccles SA, Jones C. Mol Cancer Ther; 2011 Aug 01; 10(8):1407-18. PubMed ID: 21659463 [Abstract] [Full Text] [Related]
39. Effects of Src kinase inhibition induced by dasatinib in non-small cell lung cancer cell lines treated with cisplatin. Ceppi P, Papotti M, Monica V, Lo Iacono M, Saviozzi S, Pautasso M, Novello S, Mussino S, Bracco E, Volante M, Scagliotti GV. Mol Cancer Ther; 2009 Nov 01; 8(11):3066-74. PubMed ID: 19861409 [Abstract] [Full Text] [Related]
40. Dual treatments targeting IGF-1R, PI3K, mTORC or MEK synergize to inhibit cell growth, induce apoptosis, and arrest cell cycle at G1 phase in MDA-MB-231 cell line. Ayub A, Yip WK, Seow HF. Biomed Pharmacother; 2015 Oct 01; 75():40-50. PubMed ID: 26463630 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]